Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy-Reference-Cited by-同舟云学术

Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy

Published:2018-12-06 Issue:23 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Fransen Marieke F.,Schoonderwoerd Mark,Knopf Philipp,Camps Marcel G.M.,Hawinkels Lukas J.A.C.,Kneilling Manfred,van Hall Thorbald^ORCID,Ossendorp Ferry

Funder

KWF Kankerbestrijding

Stichting Fonds Oncologie Holland

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/124507/files/pdf

Reference23 articles.

1. Targeting Immune Checkpoints in Cancer Therapy

2. Understanding the tumor immune microenvironment (TIME) for effective therapy

3. Systemic Immunity Is Required for Effective Cancer Immunotherapy

4. High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

5. Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerated Exosomal Metabolic Profiling Enabled by Robust On‐Target Array Sintering with Metal–Organic Frameworks;Small Methods;2024-09-12

2. The impact of elective cervical lymph node treatment on the tumour immune response in head and neck squamous cell carcinoma: time for a change in treatment strategy?;BJC Reports;2024-09-09

3. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

4. Dysregulation of systemic immunity and its clinical application in gastric cancer;Frontiers in Immunology;2024-09-05

5. Comment On: “Preoperative Platelet Count as an Independent Predictor of Long‐Term Outcomes Among Patients Undergoing Resection for Intrahepatic Cholangiocarcinoma”;Journal of Surgical Oncology;2024-09